- Fee assured
- Awaiting verification
- General cardiology
- Interventional cardiology
Dr Witherow trained at the University of Edinburgh Medical School and initially worked in various medical specialities throughout Scotland.
He subsequently won a prestigious British Heart Foundation research fellowship and published award-winning research, which contributed to his M.D. thesis on the role of ACE inhibition in vascular disease. He subsequently trained as a cardiology registrar in the South-East Scotland rotation specialising in invasive cardiology especially coronary intervention and won a further fellowship to train in coronary intervention via the radial artery at the Amsterdam Department of Interventional Cardiology one of Europe’s most prestigious cardiology units.
He completed his training in Edinburgh before being appointed as a locum consultant in the Royal Bournemouth Hospital prior to his current appointment as a consultant cardiologist and lead clinician for coronary intervention at Dorset County Hospital.
Dr Witherow is highly experienced in coronary intervention including the use of intravascular ultrasound, pressure wire, rotablation and specialises in highly complex coronary interventions and accepts referrals for second opinions where other cardiology teams have been unable or unwilling to take on challenging cases.
Dr Witherow has recently set up the only service for coronary sinus reducers for refractory angina in the South West.
Areas of interest
Interventional cardiology; Angina; atrial fibrillation; arrythmias; palpitations; breathlessness; chest pain; Murmurs; heart valve disease; coronary artery disease; coronary stenting; cardiomyopathy; heart failure; blackouts;
Current NHS consultant posts held
Clinical Director of Cardiology, Dorset County Hospital
Antithrombotic Therapy in PCI
New stent technologies
Second Prize British Cardiac Society Young Research Workers Prize 2000.
Second Prize Young Investigator Award for Clinical Science, American Heart Association 2003.
Finalist Challenging Cases Competition, Transcatheter Cardiovascular Therapeutics 2004.
Winner of the Best Case competition "Heart Live Meeting" 2013
Second Prize Challenging Case Competition TCT San Francisco 2013
Finalist "Radialist of the Year" awards New York 2013
Newby DE, Stewart A, Witherow FN, Greive S, Dawson P, Fox KAA, Webb DJ, Ludlam CA. Local and Systemic Effects of Intra-arterial Desmopressin in Healthy Volunteers and Patients with Type 3 von Williebrand Disease : Role of Interleukin-6. Thrombosis and Haemostasis 2000; 84:195-203.
Witherow FN, Helmy A, Webb DJ, Fox KAA, Newby DE. Bradykinin Contributes To The Vasodilator Effects Of Chronic ACE Inhibition In Patients With Heart Failure. Circulation 2001; 104:2177-2181.
Newby DE, Witherow FN, Wright RA, Bloomfield P, Ludlam CA, Boon NA, Fox KAA, Webb DJ. Hypercholesterolemia and lipid lowering therapy do not affect the acute endogenous fibrinolytic capacity in vivo. Heart 2002; 87:48-53.
Witherow FN, Dawson P, Ludlam CA, Fox KAA, Newby DE. Marked Bradykinin-Induced Tissue Plasminogen Activator Release In Patients With Heart Failure Maintained On Chronic ACE Inhibitor Therapy. J Am Coll Cardiol 2002; 40:961-6.
Witherow FN, Dawson P, Ludlam CA, Webb DJ, Fox KAA, Newby DE. Bradykinin Receptor Antagonism and Endothelial Tissue Plasminogen Activator Release in Humans. Arterioscler Thromb Vasc Biol. 2003; 23:1667-70.
Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Arterioscler Thromb Vasc Biol. 2004; 24:1043-8.
Perera D, Stables R, Booth J, Thomas M, Redwood S; BCIS-1 Investigators. The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design.
Am Heart J. 200915:910-916.
Sado D, Witherow F. Sterile granuloma formation following radial artery facilitated coronary catheterization. Catheter Cardiovasc Interv. 2009;74:606.
Fath-Ordoubadi F, Hauptmann K-E, Latib A. et al. Safety and Clinical Efficacy of Sideguard® Stent for Treatment of Bifurcation Lesions: Interim Results from the European Sideguard® Bifurcation Registry Study J Am Coll Cardiol. 2012;60(17_S):.
McMurray JJ, Packer M, Desai AS et al. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2013;15:1062-73
- MD with distinction University of Edinburgh 2005
- MB ChB University of Edinburgh 1994
- FRCPE RCPE 2009
- MRCP UK 1997
- FRCP RCP 2010
- Interventional Fellowship Amsterdam Department of Interventional Cardiology 2004
Reference number 4128470
Details of entry to specialist register
- CCT Cardiology, 2004
Affiliations / memberships
British Cardiovascular Society
British Cardiovascular Intervention Society
- BMI The Winterbourne Hospital Herringston Road...
- 14:00 - 19:00
- 0808 101 0337
- Nuffield Health Bournemouth Hospital, BH1 1RW
- 18:30 - 21:00
- 07807 369290
Post treatment communication
Private Secretary 07807369290